MEI Pharma, Inc.
MEIP
$2.05
$0.010.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 66.57% | 56.50% | -101.67% | 17.50% | -119.62% |
| Total Depreciation and Amortization | -100.00% | 194.40% | 45.35% | 1.18% | -2.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -779.55% | -99.30% | 1,097.82% | -14.17% | 67.07% |
| Change in Net Operating Assets | 89.97% | 68.41% | -343.98% | 487.66% | 98.28% |
| Cash from Operations | 67.98% | 36.39% | -514.72% | 73.51% | 40.21% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.26% | -24.85% | 15,919.67% | -99.50% | 394.73% |
| Cash from Investing | 39.16% | -24.80% | 15,919.67% | -99.50% | 394.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -- | -- | -- | 100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 417.00% | 142.86% | 147.65% | -255.72% | 113.31% |